RMD Q2 2020 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$35B

Q2 2020 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$736M+13.1% YoY

Gross Profit

$427M58.0% margin

Operating Income

$198M26.9% margin

Net Income

$161M21.8% margin

EPS (Diluted)

$1.10

QoQ Revenue Growth

+8.1%

Cash Flow

Operating Cash Flow

$70M

Free Cash Flow

$42M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$4.4B

Total Liabilities

$2.1B

Stockholders' Equity

$2.3B

Cash & Equivalents

$204M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$736M	$651M	+13.1%
Gross Profit	$427M	$384M	+11.3%
Operating Income	$198M	$157M	+25.9%
Net Income	$161M	$125M	+28.8%

Revenue Segments

Devices And Masks

$649M88%

Software As Service

$87M12%

Geographic Segments

Devices And Masks

$649M88%

Software As Service

$87M12%